Major Medical Journal Deems Paxil Unsafe for Teens
Nearly 14 years after a major medical journal conducted a study of the antidepressant medication Paxil and deemed it safe, the British Medical Journal (BMJ) has reexamined the findings and suggested that drug is actually dangerous and mislabeled.
Details of the Paxil Reanalysis
According to the New York Times, Paxil, an antidepressant drug commonly prescribed to teens and adolescents, came under fire in the late nineties for causing serious adverse side effects. People who took the medication were found to have an increased chance of committing suicide or other violent acts.
It was during this time that an extensive research study on the drug was conducted and published in the Journal of the American Academy of Child and Adolescent Psychiatry. The analysis of the study represented the drug as both safe and effective which lead to what the BMJ contends as the “mislabeling of serious side effects”.
The company which produces the drug, GlaxoSmithKline, as well as several doctors involved in the original study hotly contest this new analysis, labeling it as potentially biased (the new research team did include a psychiatrist who was a paid witness against Glaxo in several lawsuits).
In a joint statement the authors of the original study contended that the reanalysis concluding Paxil to be unsafe is “pejorative and wrong”.
Reported Paxil Side Effect Incidents
- According to Dr. Healy, one of the authors of the reanalysis, examination of patient level files in the original research revealed multiple incidents of Paxil having serious adverse side effects.
- A teen experienced suicidal thoughts after taking Paxil and was transported to the hospital after taking 80 Tylenol tablets.
- Another teen attempted suicide by overdosing on Paxil and several other drugs after a “disagreement with her mother”.
- Multiple patients reported experiencing “severe suicidal ideation” and “homicidal ideation toward (their) parents”.